Previous 10 | Next 10 |
MOUNTAIN VIEW, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year of 2019 after the close of trading on Thursday, March 12, 2020. The Company’s management te...
MOUNTAIN VIEW, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generation of the MicroPulse P3 ...
Gainers: FLNT +59.8% . OGI +27.8% . APTX +9.3% . MNTA +4.8% . OTCQB:CURR +2.0% . More news on: Fluent, Inc., OrganiGram Holdings Inc., Aptinyx Inc., Stocks on the move, , Read more ...
Gainers: RTI Surgical RTIX +66% . More news on: IRIDEX Corporation, Inpixon, Gritstone Oncology, Inc., Stocks on the move, , Read more ...
On a preliminary basis , IRIDEX (NASDAQ: IRIX ) expects Q4 and full-year revenues of $11.6M - 11.8M and $43.3M - 43.5M, respectively. More news on: IRIDEX Corporation, Healthcare stocks news, Earnings news and commentary, , Read more ...
MOUNTAIN VIEW, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 28, 2019. Highlights Total revenue for the fourth quarter of 2019 expected to ...
The following slide deck was published by IRIDEX Corporation in conjunction with this Read more ...
IRIDEX Corporation (IRIX) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Leigh Salvo – Head of Investors Relations Dave Bruce – Chief Executive Officer Romeo Dizon – Vice President of Finance Conference Call Participants ...
IRIDEX (NASDAQ: IRIX ): Q3 GAAP EPS of -$0.13 beats by $0.04 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
MOUNTAIN VIEW, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2019. Third Quarter Highlights Total revenue of $10.7 million Cyclo G6® product family revenue of $3.0 million...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...